Influence of Metaprot and Hypoxen on inflammatory-reaction development in an experiment

V. E. Novikov, S. A. Ilyukhin, E. V. Pozhilova · 2012 · Reviews on Clinical Pharmacology and Drug Therapy. 10(4):63–66

Animal / experimentalEnglish abstractSource linked

This is Molekul’s research summary, not the original publication. Educational information only, not medical advice. Seek qualified healthcare help for medical conditions.

What does this source report?

Hypoxen and Metaprot showed weak anti-inflammatory activity alone but enhanced aspirin-associated effects. The publisher abstract identifies Hypoxen plus aspirin as the most effective combination tested.

Population and setting: Carrageenan-induced rat paw inflammation
Evidence type: Animal / experimental
Preparation: See the original report; formulation details require verification.
Source language: Russian; English abstract
Title provenance: Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.

What are the limitations?

Animal inflammation endpoints are not human analgesic or performance outcomes.
The abstract wording does not establish a Hypoxen-plus-Bemitil performance regimen. Full arm definitions and safety require review.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Document format: Journal article

Review depth: Abstract reviewed

Source access and review scope

Indexed or publisher abstract reviewed; full methods and risk of bias not appraised.

Recorded source-check date: 2026-10-04. This date does not imply a completed systematic review.

Open original source or index record ↗

DOI: 10.17816/RCF10463-66

Cite and trace this record

Original source: V. E. Novikov, S. A. Ilyukhin, E. V. Pozhilova. Influence of Metaprot and Hypoxen on inflammatory-reaction development in an experiment Reviews on Clinical Pharmacology and Drug Therapy. 10(4):63–66 2012.

Molekul research summary: https://molekul.io/research/hypoxen-inflammation-2012. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Hypoxen / Olifen

A synthetic polyphenolic preparation studied in hypoxia, environmental stress, exercise and cellular-energy metabolism. Human findings are limited, and laboratory effects depend on experimental conditions.

Bemitil

A benzimidazole-derived actoprotector, also indexed as bemethyl and Metaprot. Research spans patient asthenia, occupational settings, neuromuscular and liver studies, metabolism and preclinical safety; these are research contexts, not established uses.

Editorial policy and evidence standards